CLiR No. 5 Cannabis. A new way to make science

Page 52

50

TETRAHIDROCANNABINOL (THC), GENETIC VARIABILITY AND VARIABILITY IN PHARMACOLOGICAL RESPONSE The most frequent drug of consumption in the world is marijuana, with a 3.8% prevalence (around 183 million people), followed by amphetamines and amphetamine-type stimulants(1). In Mexico, there is an estimated 14.0% of men and 3.7% of women who uses it; Additionally, it is the drug with the highest increase in consumption, both in men and women. The risk perception of marijuana use is involved in this growth, it has fallen below 40%, while in other substances such as cocaine or inhalants it reaches values above 62%(2).

Javier Esquivel Vargas, Diana Vega Perea, Darío Morales Martínez, Miriam Morales Mtz., Alberto García González, Alionka Citlali P. Ángeles Grupo Phi Innovación y Desarrollo Científico, S.A.P.I. de C.V.

Cannabis is a plant native to Mongolia and southern Siberia. America’s first contact with it was through Christopher Columbus, who transported in his boats an estimated 80 tons of sails and ropes made of hemp. Later, during the conquest period (~ 1521), Hernán Cortés imported several plants from Europe and Asia, including C. sativa and C. indica, to boost the economy of New Spain(3). The Cannabis Sativa plant belongs to the Cannabaceae family (4), it is composed for more than 545 substances (5) from 18 types of chemical compounds (4), where at least 120 phytocannabinoids have been identified (6). Phytocannabinoids can be divided into 11 classes, depending on their chemical structure: cannabigerol, (-) - 19-tetrahydrocannabinol, cannabidiol, cannabichromene, cannabinol, (-) - 18 tetrahydrocannabinol, cannabicyclol, cannabinodiol, cannabielsoin, cannabitriol and miscellaneous (7). Most of the biological properties of cannabinoids lie in their interaction with the human endocannabinoid system. This system includes two G protein coupled to cannabinoid receptors, CB1 and CB2, as well as two endogenous ligands, anandamide and 2-arachidonylglycerol (8). Among cannabinoids, Δ9-Tetrahydrocannabinol (THC) has the highest psychoactive strenght(9). It has shown analgesic, immunosuppressive and muscle relaxant, antiinflammatory, appetite modulator, antidepressant, antiemetic, bronchodilator, neuroleptic, antineoplastic and antiallergen effects (10); however, it has also been associated with some side effects, including anxiety, cholinergic deficit, severe immunosuppression, hallucinations, paranoia, and tachycardia. These adverse effects have been commonly associated with car accidents, work injuries, and hospitalizations (11).

| CLINICAL RESEARCH & PHARMACOLOGY


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Use of cannabis as a potential treatment for Inflamatory Bowel Disease (IBD) - Dra. Ana Villaseñor-Todd

9min
pages 24-28

TETRAHIDROCANNABINOL (THC), GENETIC VARIABILITY AND VARIABILITY IN PHARMACOLOGICAL RESPONSE

8min
pages 52-55

ADVERSE FINANCIAL EVENTS CAN BE A SIGN OF DEMENTIA

1min
page 7

CHOCOLATE HEALTH CLAIMS

1min
page 7

PANDEMIC ADVERSE EVENTS: UNDERDIAGNOSIS OF OTHER DISEASES, THE CASE OF TUBERCULOSIS IN AMERICA

1min
page 6

DREXEL UNIVERSITY IN PHILADELPHIA OPENS MEDICAL CANNABIS RESEARCH CENTER

1min
page 6

Viola Brugnatelli: Scientific research, innovation, and awareness

2min
pages 62-64

"Chewing the soul” poem by Marco Antonio Gabriel

1min
page 65

How to smoke marijuana and have a good trip. A sociological look

5min
pages 60-61

Morphology and physiology between subspecies and sexes of Cannabis

12min
pages 36-41

Cannabis and technology: The new non-stigma of the 21st century. Mauro Orozco

3min
pages 57-59

The creative and inventive boom of Cannabis. Enrique U. Alcázar

7min
pages 46-56

Legal cannabinoid-based medicine in Mexico: challenges and perspectives

7min
pages 32-35

Cannabis in Latin America: the bloom of an industry under a new paradigm. Gerardo Garza Villarreal et al.

3min
pages 30-31

Cannabis, the controversy updated. Guillermo Caletti

5min
pages 42-45

Interview to Lorena Beltrán, one of the most prominent investigators and activists of Cannabis in Latin America

15min
pages 16-29

Does cannabis really have a medicinaluse? Why?

2min
pages 14-15

Cannabis old and new, risks and opportunities. Thor Nissen

3min
pages 11-12

Let us all build a solid industry! Israel Madrid

2min
page 9

EDITORIAL

2min
page 5

Our Cages. Dante Alducin

3min
page 13

Cannabis, beyond the myth. Marco A. Cid

2min
page 8

Cannabis’ new appraisal in Mexico. Midalia Denisse Arias

2min
page 10
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.